Výsledky vyhledávání - "Lars, Viktrup"

Akademický článek

Patients’ Experiences During the Long Journey Before Initiating Migraine Prevention with a Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody (mAb)

Autor: Elizabeth Seng, Christian Lampl, Lars Viktrup, William R. Lenderking, Hayley Karn, Margaret Hoyt, Gilwan Kim, Dustin Ruff, Michael H. Ossipov, Maurice Vincent

Publikováno v: Pain and Therapy, Vol 13, Iss 6, Pp 1589-1615 (2024)

Abstract Introduction Migraine is under-diagnosed and under-treated. Many people with migraine do not seek medical care, and those who do may initially receive a different diagnosis and/or be dissatisfied with provided care on their journey before tr

Externí odkaz: https://doaj.org/article/26e4ae2941454fc8ac6a50facae35346

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Effect size varies based on calculation method and may affect interpretation of treatment effect: an illustration using randomised clinical trials in osteoarthritis

Autor: Thomas J. Schnitzer, Philip G. Conaghan, Francis Berenbaum, Lucy Abraham, Joseph C. Cappelleri, Andrew G. Bushmakin, Lars Viktrup, Ruoyong Yang, Mark T. Brown

Publikováno v: Advances in Rheumatology, Vol 64, Iss 1, Pp 1-5 (2024)

Abstract Background To illustrate how (standardised) effect sizes (ES) vary based on calculation method and to provide considerations for improved reporting. Methods Data from three trials of tanezumab in subjects with osteoarthritis were analyzed. E

Externí odkaz: https://doaj.org/article/f628c39303c84570a9c6556e1bdaf14a

Zobrazit plný text záznamu

Akademický článek

Factors associated with physician-reported treatment status of patients with osteoarthritis pain

Autor: Thomas J. Schnitzer, Rebecca L. Robinson, Leslie Tive, Joseph C. Cappelleri, Andrew G. Bushmakin, James Jackson, Mia Berry, Sophie Barlow, Chloe Walker, Lars Viktrup

Publikováno v: BMC Musculoskeletal Disorders, Vol 23, Iss 1, Pp 1-11 (2022)

Abstract Background Osteoarthritis (OA) is typically associated with pain, but many patients are not treated. Methods This point in time study explored factors associated with treatment status, using logistic regression of data from the Adelphi OA Di

Externí odkaz: https://doaj.org/article/1351e9edafac4d478b2f29c1d7397972

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study

Autor: Tuhina Neogi, David J. Hunter, Melvin Churchill, Ivan Shirinsky, Alexander White, Ali Guermazi, Masanari Omata, Robert J. Fountaine, Glenn Pixton, Lars Viktrup, Mark T. Brown, Christine R. West, Kenneth M. Verburg

Publikováno v: Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-13 (2022)

Abstract Background A recent phase 3 study demonstrated that treatment with tanezumab, a nerve growth factor inhibitor, or nonsteroidal anti-inflammatory drugs (NSAIDs) improves pain and physical function in participants with moderate-to-severe osteo

Externí odkaz: https://doaj.org/article/81e12a8d1d7a491790792756213dd7a2

Zobrazit plný text záznamu

Akademický článek

Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritis

Autor: Philip G. Conaghan, Lucy Abraham, Lars Viktrup, Paul Cislo

Publikováno v: BMC Musculoskeletal Disorders, Vol 23, Iss 1, Pp 1-10 (2022)

Abstract Background To evaluate the impact of tanezumab on health status, non-work activities, and work productivity in a pooled analysis of two large phase 3 osteoarthritis (OA) studies. Methods Subcutaneous tanezumab (2.5 mg and 5 mg) was tested in

Externí odkaz: https://doaj.org/article/69f48b9ed7a14c38a94a212344ad8862

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

The not so hidden impact of interictal burden in migraine: A narrative review

Autor: Maurice Vincent, Lars Viktrup, Robert A. Nicholson, Michael H. Ossipov, Bert B. Vargas

Publikováno v: Frontiers in Neurology, Vol 13 (2022)

Migraine is a highly prevalent neurological disease of varying attack frequency. Headache attacks that are accompanied by a combination of impact on daily activities, photophobia and/or nausea are most commonly migraine. The headache phase of a migra

Externí odkaz: https://doaj.org/article/5d717d930b334f39b8509c42eb40e931

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání